Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5168

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5168 3)

Pdp (68071 5168 3)
The text is a warning about controlling the temperature of drugs made by "are Pharmaceuticals, Inc." with a product code of #631. The warning also indicates to keep the product out of reach of children. The product is in tablet form, with an oval shape, and a white or off-white color. Each film-coated tablet contains Atorvastatin Calcium 20m, and the package includes 30 tablets. The text also provides information on the manufacturer's NDC and expiration date, as well as a serial and LOT number. Retailers can contact the manufacturer at the GTIN code provided for medical advice about side effects.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

Figure (Atorvastatin Calcium Figure 1)
Not available.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
This is a graph showing the cumulative hazard percentage over 4 years of follow-up for a placebo group and a group taking atorvastatin. The hazard ratio (HR), confidence interval, and p-value are also provided. The primary endpoint is not specified.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
This is a description of the percentage of subjects who experienced an event in a study comparing the effectiveness of two doses of Atorvastatin (10mg and 80mg). The study found that Atorvastatin 80mg was associated with a lower risk of cardiovascular events compared to 10mg. The HR (Hazard Ratio) was 0.78, indicating a 22% decrease in the risk of cardiovascular events with Atorvastatin 80mg. The time to the first major cardiovascular event was not specified.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.